These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6444322)

  • 21. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes.
    Webster GF; Leyden JJ
    Inflammation; 1980 Sep; 4(3):261-9. PubMed ID: 7429606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes.
    Wang Y; Kao MS; Yu J; Huang S; Marito S; Gallo RL; Huang CM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propionibacteria in patients with acne vulgaris and in healthy persons.
    Gehse M; Höffler U; Gloor M; Pulverer G
    Arch Dermatol Res; 1983; 275(2):100-4. PubMed ID: 6223602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum.
    Lee WL; Shalita AR; Poh-Fitzpatrick MB
    J Bacteriol; 1978 Feb; 133(2):811-5. PubMed ID: 637914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of antibody to Staphylococcus epidermidis in patients with acne vulgaris.
    Puhvel SM; Warnick MA; Sternberg TH
    Arch Dermatol; 1965 Jul; 92(1):88-90. PubMed ID: 11850964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of hyaluronidase by propionibacteria from different origins.
    Höffler U
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):123-9. PubMed ID: 44604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microbial content and complement C3 cleaving capacity of comedones in acne vulgaris.
    Leeming JP; Ingham E; Cunliffe WJ
    Acta Derm Venereol; 1988; 68(6):468-73. PubMed ID: 2467483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte activating factor released from Propionibacterium acnes. A possible mediator of inflammation in acne vulgaris.
    Pulverer G; Roszkowski W; Beuth HJ; Ko HL; Quie P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):246-51. PubMed ID: 2975904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minocycline effectively reduces acid producted by Propionibacterium granulosum.
    Higaki S; Kitagawa T; Morohashi M; Yamagishi T
    J Dermatol; 2002 Jan; 29(1):20-2. PubMed ID: 11837569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differentiation of various Propionibacterium species from acne-vulgaris efflorescences].
    Lentze I; Ko HL; Höffler U
    Hautarzt; 1979 May; 30(5):242-7. PubMed ID: 156167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
    Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
    J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system.
    De Young LM; Spires DA; Ballaron SJ; Cummins CS; Young JM; Allison AC
    J Invest Dermatol; 1985 Sep; 85(3):255-8. PubMed ID: 3161957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
    Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
    Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V; Legallou F; Richet H; Dreno B
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
    Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of elastolytic activity Propionibacterium acnes and Staphylococcus epidermis in acne vulgaris and in normal skin.
    Dick GF; Ashe BM; Rodgers EG; Diercks RC; Goltz RW
    Acta Derm Venereol; 1976; 56(4):279-82. PubMed ID: 60023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of anti-acne properties of phloretin in vitro and in vivo.
    Kum H; Roh KB; Shin S; Jung K; Park D; Jung E
    Int J Cosmet Sci; 2016 Feb; 38(1):85-92. PubMed ID: 26212527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytotoxicity in acne vulgaris].
    Vignale RA; Espasandín J; Lasalvia E; Borras A
    Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.